trending Market Intelligence /marketintelligence/en/news-insights/trending/CtyKvizmLfV_5nWMmVCfXA2 content esgSubNav
In This List

BioLineRx chief scientific officer to step down

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


BioLineRx chief scientific officer to step down

BioLineRx Ltd.'s chief scientific officer, Merril Gersten, will step down March 31.

The company is yet to announce a replacement for Gersten.